Obesity and Type 2 Diabetes

Defining CMR - Epidemiology - Abdominal Obesity vs. Type 2 Diabetes: Beyond Body Weight

Key Points

  • Changes in human behaviour and lifestyle over the last century have spurred a dramatic increase in the incidence of obesity and type 2 diabetes worldwide.
  • Because obesity and diabetes are closely linked, the term “diabesity” has been coined to illustrate the interdependence of these two diseases.
  • Obesity and type 2 diabetes frequently occur together and the majority of patients with type 2 diabetes are or have been obese.
  • Besides genetic susceptibility, obesity is the most important risk factor for type 2 diabetes.
  • Lifestyle changes are the best way to prevent obesity and slow this worldwide epidemic.

The “Diabesity” Epidemic

Developed societies face two crucial health problems: overweight and obesity. Obesity is the most common metabolic disease, and the number of individuals who are overweight or obese is fast increasing worldwide [1]. Increased body fat has been linked to numerous co-morbidities such as dyslipidemia, cardiovascular disease (CVD), and type 2 diabetes [2]. The rapid, global increase in obesity has also sparked an increase in cases of type 2 diabetes [3]. Lifestyle and environment changes have sent the rates of both obesity and diabetes soaring [4]. The end result is that, over the past two decades, the number of individuals with diabetes has skyrocketed worldwide [5,6]. All signs indicate that the diabetes epidemic will continue to escalate. It has been suggested that there will be more than 700 million individuals with diabetes by the year 2045 [7].

The term “diabesity” has been coined to illustrate the close relationship between obesity and diabetes [8,9]. Obesity and type 2 diabetes frequently occur together and the vast majority of type 2 diabetic individuals are obese [10,11]. In combination with genetic susceptibility, obesity is the most important type 2 diabetes risk factor [12,13]. The relative risk of developing type 2 diabetes increases tenfold in obese women and elevenfold in obese men [14]. Obesity is therefore a major risk factor for type 2 diabetes.

Obesity and Type 2 Diabetes: Epidemiological Evidence

Many cross-sectional and prospective studies have confirmed the link between obesity and type 2 diabetes. Most individuals with type 2 diabetes are overweight or obese. Studies suggest that about 60-90% of all patients with type 2 diabetes are or have been obese [10,11]. One of the first observations on the association between obesity and type 2 diabetes was published by John in 1929 [15]. In the 1960s, the seminal population studies of West and Kalbfleisch [16] demonstrated the strong association between overweight and diabetes. They reported that a population’s degree of obesity was the key environmental factor influencing diabetes prevalence [17]. Similarly, a study conducted in the Pima Indian population—a community at high risk of type 2 diabetes—revealed that the probability of developing type 2 diabetes rose with increasing body mass index (BMI) [18]. More recently, data from the Third National Health and Nutrition Examination Survey (NHANES III) [19] showed a strong increase in type 2 diabetes among both overweight and obese men and women with increasing weight classes. Recent prospective studies have also tied increasing weight to an increased risk of type 2 diabetes. For instance, the Nurses’ Health Study [20]—a 14 year follow-up study of 11,824 women aged 30-55 years—found the risk of developing type 2 diabetes was 49 times higher among women whose baseline BMI was >35 kg/m2 than among women whose baseline BMI was <22 kg/m2 (Figure). The risk of developing the disease increased fourfold when BMI was between 23.0 and 25.0 kg/m2 and even lean women with a BMI of 22.0 to 22.9 kg/m2 had a significant threefold increase in their risk of type 2 diabetes compared to women with a BMI <22.0 kg/m2. They also found that weight gain of 7.0 to 10.9 kg after the age of 18 was associated with a twofold increase in the risk of type 2 diabetes, the increase in risk being proportionate to the degree of weight gain.

Thrifty Genotype vs. Thrifty Phenotype

Environmental and behavioural factors (sedentary lifestyle and poor nutrition) have contributed to the worldwide epidemic of obesity and type 2 diabetes. However, one of the major debates in diabetes etiology is the notion of “thrifty genotype” versus “thrifty phenotype” [7]. The “thrifty genotype” concept suggests that a predisposition to type 2 diabetes may result from a genotype that promotes fat storage during famine periods—a possible evolutionary advantage. This hypothesis partly explains the high prevalence of type 2 diabetes in Pima Indians, a population genetically prone to type 2 diabetes. When this specific genotype is exposed to an obesogenic environment (a diet high in simple refined carbohydrates and saturated fat, combined with a sedentary lifestyle), obesity and type 2 diabetes soon follow. The “thrifty phenotype” hypothesis—which is based on the observation that low birth weight is an important risk factor for type 2 diabetes [21]— suggests that type 2 diabetes is mainly caused by early environmental factors and by genetic factors to a much lesser extent. However, given the compelling evidence in support of the role of genetic factors in type 2 diabetes, it is likely that both hypotheses may modulate type 2 diabetes risk, although some believe that the “thrifty genotype” theory will prevail over the “thrifty phenotype” theory.

Overweight and obesity are critical health problems in our modern society. Both conditions significantly increase the risk of type 2 diabetes and CVD. Yet obesity does not occur in a vacuum. It is a complex disorder in which environmental and behavioural factors interact with genetic susceptibility. All these factors combined have contributed to the worldwide obesity and type 2 diabetes epidemic.

References

  1. World Health Organization, Obesity and overweight. Key facts. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight, Accessed October 4, 2022.

    PubMed ID:
  2. Bray GA, Bouchard C and James WPT, eds. Handbook of obesity. New York: Marcel Dekker. 1998.

    PubMed ID:
  3. Ford ES, Williamson DF and Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997; 146: 214-22.

    PubMed ID: 9247005
  4. Zimmet P, Alberti KG and Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.

    PubMed ID: 11742409
  5. Amos AF, McCarty DJ and Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14 Suppl 5: S1-85.

    PubMed ID: 9450510
  6. King H, Aubert RE and Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.

    PubMed ID: 9727886
  7. International Diabetes Federation. Diabetes facts and figures. www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html.

    PubMed ID:
  8. Astrup A and Finer N. Redefining type 2 diabetes: ‘diabesity’ or ‘obesity dependent diabetes mellitus’? Obes Rev 2000; 1: 57-9.

    PubMed ID: 12119987
  9. Shafrir E. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes Metab 1996; 22: 122-31.

    PubMed ID: 8792092
  10. Halpern A and Mancini MC. Diabesity: are weight loss medications effective? Treat Endocrinol 2005; 4: 65-74.

    PubMed ID: 15783244
  11. Stumvoll M, Goldstein BJ and van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365: 1333-46.

    PubMed ID: 15823385
  12. DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 1997; 5: 177-269.

    PubMed ID:
  13. Scheen AJ. Pathophysiology of type 2 diabetes. In: Kuhlman J, Puls W, eds, Handbook of Experimental Pharmacology, Oral Antidiabetics (Springer Verlag: Berlin) 1996; 7-42.

    PubMed ID:
  14. Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001; 161: 1581-6.

    PubMed ID: 11434789
  15. John H. Summary of findings in 1100 glucose tolerance estimations. Endocrinology 1929; 13: 388-92.

    PubMed ID:
  16. West KM and Kalbfleisch JM. Glucose tolerance, nutrition, and diabetes in Uruguay, Venezuela, Malaya, and East Pakistan. Diabetes 1966; 15: 9-18.

    PubMed ID: 5907153
  17. West KM and Kalbfleisch JM. Influence of nutritional factors on prevalence of diabetes. Diabetes 1971; 20: 99-108.

    PubMed ID: 5100965
  18. Knowler WC, Pettitt DJ, Savage PJ, et al. Diabetes incidence in Pima indians: contributions of obesity and parental diabetes. Am J Epidemiol 1981; 113: 144-56.

    PubMed ID: 7468572
  19. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-9.

    PubMed ID: 10546691
  20. Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-6.

    PubMed ID: 7872581
  21. Hales CN and Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601.

    PubMed ID: 1644236
Reference 1 CLOSECLOSE

World Health Organization, Obesity and overweight. Key facts. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight, Accessed October 4, 2022.

PubMed ID:
Reference 2 CLOSECLOSE

Bray GA, Bouchard C and James WPT, eds. Handbook of obesity. New York: Marcel Dekker. 1998.

PubMed ID:
Reference 3 CLOSECLOSE

Ford ES, Williamson DF and Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997; 146: 214-22.

PubMed ID: 9247005
Reference 4 CLOSECLOSE

Zimmet P, Alberti KG and Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.

PubMed ID: 11742409
Reference 5 CLOSECLOSE

Amos AF, McCarty DJ and Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14 Suppl 5: S1-85.

PubMed ID: 9450510
Reference 6 CLOSECLOSE

King H, Aubert RE and Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.

PubMed ID: 9727886
Reference 7 CLOSECLOSE

International Diabetes Federation. Diabetes facts and figures. www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html.

PubMed ID:
Reference 8 CLOSECLOSE

Astrup A and Finer N. Redefining type 2 diabetes: ‘diabesity’ or ‘obesity dependent diabetes mellitus’? Obes Rev 2000; 1: 57-9.

PubMed ID: 12119987
Reference 9 CLOSECLOSE

Shafrir E. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes Metab 1996; 22: 122-31.

PubMed ID: 8792092
Reference 10 CLOSECLOSE

Halpern A and Mancini MC. Diabesity: are weight loss medications effective? Treat Endocrinol 2005; 4: 65-74.

PubMed ID: 15783244
Reference 11 CLOSECLOSE

Stumvoll M, Goldstein BJ and van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365: 1333-46.

PubMed ID: 15823385
Reference 12 CLOSECLOSE

DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 1997; 5: 177-269.

PubMed ID:
Reference 13 CLOSECLOSE

Scheen AJ. Pathophysiology of type 2 diabetes. In: Kuhlman J, Puls W, eds, Handbook of Experimental Pharmacology, Oral Antidiabetics (Springer Verlag: Berlin) 1996; 7-42.

PubMed ID:
Reference 14 CLOSECLOSE

Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001; 161: 1581-6.

PubMed ID: 11434789
Reference 15 CLOSECLOSE

John H. Summary of findings in 1100 glucose tolerance estimations. Endocrinology 1929; 13: 388-92.

PubMed ID:
Reference 16 CLOSECLOSE

West KM and Kalbfleisch JM. Glucose tolerance, nutrition, and diabetes in Uruguay, Venezuela, Malaya, and East Pakistan. Diabetes 1966; 15: 9-18.

PubMed ID: 5907153
Reference 17 CLOSECLOSE

West KM and Kalbfleisch JM. Influence of nutritional factors on prevalence of diabetes. Diabetes 1971; 20: 99-108.

PubMed ID: 5100965
Reference 18 CLOSECLOSE

Knowler WC, Pettitt DJ, Savage PJ, et al. Diabetes incidence in Pima indians: contributions of obesity and parental diabetes. Am J Epidemiol 1981; 113: 144-56.

PubMed ID: 7468572
Reference 19 CLOSECLOSE

Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-9.

PubMed ID: 10546691
Reference 20 CLOSECLOSE

Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-6.

PubMed ID: 7872581
Reference 21 CLOSECLOSE

Hales CN and Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601.

PubMed ID: 1644236